DUBLIN--(BUSINESS WIRE)--The "Occlusion
Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction
Device, Coil Embolization, Liquid Embolics), Application (Cardiology,
Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User -
Global Forecast to 2023" report has been added to ResearchAndMarkets.com's
offering.
The global occlusion devices market is projected to
reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR
of 5.3%. This report broadly segments the occlusion devices market into
product, application, end user, and region.
On the basis of
product, in 2018, the occlusion removal devices segment is expected to
account for the largest share of the market. This can be attributed to
the increasing research activity to validate the clinical efficacy of
novel occlusion removal devices (such as stent retrievers, coil
retrievers, and balloon occlusion devices) and growing patient
preference for minimally invasive surgeries.
Based on
application, the neurology applications segment accounted for the
largest share of the market in 2017. The increasing number of target
neurosurgical procedures across major countries, growing research in the
field of interventional neurology, strengthening research capabilities
of major product manufacturers, and favorable reimbursement scenario for
neurovascular surgeries across developed countries are the key factors
supporting the growth of the occlusion devices market for neurology
applications.
Based on end-user, in 2018, the hospitals,
diagnostic centers, and surgical centers segment is expected to account
for the largest share of the market due to the growing adoption of
minimally invasive surgical procedures, increasing purchasing power of
major end users across developed countries, and the availability of
reimbursements for target procedures in the US and major European
countries.
Market Dynamics
Drivers
- Expansion of Target Patient Population Base
- Technological Advancements
- Favorable Reimbursement Scenario for Minimally Invasive Surgeries
- Rising Number of Minimally Invasive Vascular Surgeries
- Focus on Expansion of Manufacturing & Distribution Capabilities in Emerging Markets
- Clinical Evidence for Safety and Efficacy of Occlusion Devices
Restraints
- Procedural Limitations Associated With CTO Treatment
- Stringent Regulatory Framework for Product Commercialization
Opportunities
- Rising Healthcare Expenditure Across Developing Countries
Challenge
- Dearth of Skilled Surgeons
Key Topics Covered
1 Introduction
2
Research Methodology
3 Executive Summary
4 Premium
Insights
5 Market Overview
6 Occlusion Devices
Market, By Product
7 Occlusion Devices Market, By Application
8
Occlusion Devices Market, By End-User
9 Occlusion Devices
Market, By Region
10 Competitive Landscape
11
Company Profiles
- Abbott Laboratories
- Acrostak
- Angiodynamics
- Asahi Intecc
- Avinger
- Boston Scientific
- B. Braun
- Cardinal Health
- Cook Group
- C.R. Bard (A Part of Becton Dickinson)
- Edwards Lifesciences
- Medtronic
- Penumbra
- Stryker Corporation
- Terumo Corporation
For more information about this report visit https://www.researchandmarkets.com/research/5gsr2j/occlusion?w=4
